Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

US Patent 10106620 · Granted Oct 23, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of producing modified natural killer cells and methods of use2025
EGFR and C-met fibronectin type III domain binding molecules2025
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against t2025
GPRC5D chimeric antigen receptors and cells expressing the same2024
Vaccines based on mutant CALR and JAK2 and their uses2024
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2024
HERV-E reactive T cell receptors and methods of use2023
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D an2023
Methods of producing modified natural killer cells and methods of use2022
EGFR and c-Met fibronectin type III domain binding molecules2021
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against t2020
Method of treating cancer by administering multivalent fibronectin based scaffol2020